04/28/2026 12:42
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder

Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press releas...

Communiqués de presse
EQS Group

AFP and Jiji Press Announce Launch of “Fastlook” Japanese News Platform

Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.

Agence France-Presse (AFP) and Jiji Press today announced the launch of “Fastlook”, a new platform that will bring AFP’s unparalleled global news coverage to corporate and institutional clients in Japanese. This is the first collaborative service in our more than 75-year history.
Anglais
Subscribe to